Literature DB >> 25855740

Transformation with oncogenic Ras and the simian virus 40 T antigens induces caspase-dependent sensitivity to fatty acid biosynthetic inhibition.

Shihao Xu1, Cody M Spencer1, Joshua Munger2.   

Abstract

UNLABELLED: Oncogenesis is frequently accompanied by the activation of specific metabolic pathways. One such pathway is fatty acid biosynthesis, whose induction is observed upon transformation of a wide variety of cell types. Here, we explored how defined oncogenic alleles, specifically the simian virus 40 (SV40) T antigens and oncogenic Ras(12V), affect fatty acid metabolism. Our results indicate that SV40/Ras(12V)-mediated transformation of fibroblasts induces fatty acid biosynthesis in the absence of significant changes in the concentration of fatty acid biosynthetic enzymes. This oncogene-induced activation of fatty acid biosynthesis was found to be mammalian target of rapamycin (mTOR) dependent, as it was attenuated by rapamycin treatment. Furthermore, SV40/Ras(12V)-mediated transformation induced sensitivity to treatment with fatty acid biosynthetic inhibitors. Pharmaceutical inhibition of acetyl-coenzyme A (CoA) carboxylase (ACC), a key fatty acid biosynthetic enzyme, induced caspase-dependent cell death in oncogene-transduced cells. In contrast, isogenic nontransformed cells were resistant to fatty acid biosynthetic inhibition. This oncogene-induced sensitivity to fatty acid biosynthetic inhibition was independent of the cells' growth rates and could be attenuated by supplementing the medium with unsaturated fatty acids. Both the activation of fatty acid biosynthesis and the sensitivity to fatty acid biosynthetic inhibition could be conveyed to nontransformed breast epithelial cells through transduction with oncogenic Ras(12V). Similar to what was observed in the transformed fibroblasts, the Ras(12V)-induced sensitivity to fatty acid biosynthetic inhibition was independent of the proliferative status and could be attenuated by supplementing the medium with unsaturated fatty acids. Combined, our results indicate that specific oncogenic alleles can directly confer sensitivity to inhibitors of fatty acid biosynthesis. IMPORTANCE: Viral oncoproteins and cellular mutations drive the transformation of normal cells to the cancerous state. These oncogenic alterations induce metabolic changes and dependencies that can be targeted to kill cancerous cells. Here, we find that the cellular transformation resulting from combined expression of the SV40 early region with an oncogenic Ras allele is sufficient to induce cellular susceptibility to fatty acid biosynthetic inhibition. Inhibition of fatty acid biosynthesis in these cells resulted in programmed cell death, which could be rescued by supplementing the medium with nonsaturated fatty acids. Similar results were observed with the expression of oncogenic Ras in nontransformed breast epithelial cells. Combined, our results suggest that specific oncogenic alleles induce metabolic dependencies that can be exploited to selectively kill cancerous cells.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25855740      PMCID: PMC4474286          DOI: 10.1128/JVI.03671-14

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  37 in total

1.  On the origin of cancer cells.

Authors:  O WARBURG
Journal:  Science       Date:  1956-02-24       Impact factor: 47.728

2.  Metabolism of neoplastic tissue. IV. A study of lipid synthesis in neoplastic tissue slices in vitro.

Authors:  G MEDES; A THOMAS; S WEINHOUSE
Journal:  Cancer Res       Date:  1953-01       Impact factor: 12.701

3.  Akt stimulates aerobic glycolysis in cancer cells.

Authors:  Rebecca L Elstrom; Daniel E Bauer; Monica Buzzai; Robyn Karnauskas; Marian H Harris; David R Plas; Hongming Zhuang; Ryan M Cinalli; Abass Alavi; Charles M Rudin; Craig B Thompson
Journal:  Cancer Res       Date:  2004-06-01       Impact factor: 12.701

4.  Matrix adhesion and Ras transformation both activate a phosphoinositide 3-OH kinase and protein kinase B/Akt cellular survival pathway.

Authors:  A Khwaja; P Rodriguez-Viciana; S Wennström; P H Warne; J Downward
Journal:  EMBO J       Date:  1997-05-15       Impact factor: 11.598

5.  Phosphatidylinositol-3-OH kinase as a direct target of Ras.

Authors:  P Rodriguez-Viciana; P H Warne; R Dhand; B Vanhaesebroeck; I Gout; M J Fry; M D Waterfield; J Downward
Journal:  Nature       Date:  1994-08-18       Impact factor: 49.962

6.  Creation of human tumour cells with defined genetic elements.

Authors:  W C Hahn; C M Counter; A S Lundberg; R L Beijersbergen; M W Brooks; R A Weinberg
Journal:  Nature       Date:  1999-07-29       Impact factor: 49.962

7.  Elevated expression of fatty acid synthase and fatty acid synthetic activity in colorectal neoplasia.

Authors:  A Rashid; E S Pizer; M Moga; L Z Milgraum; M Zahurak; G R Pasternack; F P Kuhajda; S R Hamilton
Journal:  Am J Pathol       Date:  1997-01       Impact factor: 4.307

8.  Inhibition of fatty acid synthesis induces programmed cell death in human breast cancer cells.

Authors:  E S Pizer; C Jackisch; F D Wood; G R Pasternack; N E Davidson; F P Kuhajda
Journal:  Cancer Res       Date:  1996-06-15       Impact factor: 12.701

9.  Isozyme-nonselective N-substituted bipiperidylcarboxamide acetyl-CoA carboxylase inhibitors reduce tissue malonyl-CoA concentrations, inhibit fatty acid synthesis, and increase fatty acid oxidation in cultured cells and in experimental animals.

Authors:  H James Harwood; Stephen F Petras; Lorraine D Shelly; Lawrence M Zaccaro; David A Perry; Michael R Makowski; Diane M Hargrove; Kelly A Martin; W Ross Tracey; Justin G Chapman; William P Magee; Deepak K Dalvie; Victor F Soliman; William H Martin; Christian J Mularski; Shane A Eisenbeis
Journal:  J Biol Chem       Date:  2003-07-03       Impact factor: 5.157

10.  Fatty acid synthesis: a potential selective target for antineoplastic therapy.

Authors:  F P Kuhajda; K Jenner; F D Wood; R A Hennigar; L B Jacobs; J D Dick; G R Pasternack
Journal:  Proc Natl Acad Sci U S A       Date:  1994-07-05       Impact factor: 11.205

View more
  1 in total

1.  Nanoformulation of Brain-Derived Neurotrophic Factor with Target Receptor-Triggered-Release in the Central Nervous System.

Authors:  Yuhang Jiang; James M Fay; Chi-Duen Poon; Natasha Vinod; Yuling Zhao; Kristin Bullock; Si Qin; Devika S Manickam; Xiang Yi; William A Banks; Alexander V Kabanov
Journal:  Adv Funct Mater       Date:  2017-12-07       Impact factor: 18.808

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.